BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cassese G, Han H, Lee B, Lee HW, Cho JY, Troisi R. Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma. Cancers 2022;14:2012. [DOI: 10.3390/cancers14082012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Endo Y, Moazzam Z, Woldesenbet S, Lima HA, Alaimo L, Munir MM, Shaikh CF, Yang J, Azap L, Katayama E, Kitago M, Pawlik TM. Hospital Volume and Textbook Outcomes in Minimally Invasive Hepatectomy for Hepatocellular Carcinoma. J Gastrointest Surg 2023. [PMID: 36732402 DOI: 10.1007/s11605-023-05609-9] [Reference Citation Analysis]
2 Cassese G, Han HS, Cho JY, Lee HW, Lee B, Troisi RI. Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma. Cancers (Basel) 2022;14. [PMID: 36497478 DOI: 10.3390/cancers14235997] [Reference Citation Analysis]
3 Cassese G, Han HS, Lee B, Lee HW, Cho JY, Panaro F, Troisi RI. Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease. World J Hepatol 2022;14:1862-74. [PMID: 36340753 DOI: 10.4254/wjh.v14.i10.1862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cassese G, Han H, Yoon Y, Lee JS, Cho JY, Lee H, Lee B, Troisi RI. Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives. Diagnostics 2022;12:1630. [DOI: 10.3390/diagnostics12071630] [Reference Citation Analysis]